Exagen Inc. Reports Strong Q2 2025 Results
Provided By GlobeNewswire
Last update: Jul 29, 2025
CARLSBAD, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2025, and recent corporate updates.
Read more at globenewswire.com9.38
+0.18 (+1.96%)
Find more stocks in the Stock Screener
XGN Latest News and Analysis
